Physiological basis of cystic fibrosis: A historical perspective

Physiological Reviews

Volumn 79, Issue 1 SUPPL. 1, 1999, Pages

  Quinton, Paul M ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; ALPHA GLUCOSIDASE; ARGININE ESTERASE; CALCIUM ION; CHLORIDE ION; GALACTOSYLTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; POTASSIUM ION; PROTEINASE; SODIUM ION; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CYSTIC FIBROSIS; ELECTROLYTE TRANSPORT; GENETIC DISORDER; GENITAL SYSTEM; HISTORY OF MEDICINE; HUMAN; MUCUS; NONHUMAN; PANCREAS DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; STEATORRHEA; SWEAT GLAND;

EID: 0032913809     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.1999.79.1.S3     Document Type: Review

References (275)

1. AL-AWQATI, Q., J. BARASCH, AND D. LANDRY. Chloride channels of intracellular organelles and their potential role in cystic fibrosis. J. Exp. Biol. 172: 245-266, 1992.
2. ALHADEFF, J. A., B. C. POLLACK, R. L. HOPFER, AND D. S. HOLSCLAW. Serum neutral alpha-D-glucosidase from patients with cystic fibrosis and chronic pulmonary disease. Pediatr. Res. 19: 171-174, 1985.
3. ALONSO Y DE LOS RUYZES DE FONTECA, J. Diez Previlegios para Mgeres Preñadas. Henares, Spain: Alcalá de Henares, 1606, p. 212.
4. ANDERSEN, D. H. Cystic fibrosis of the pancreas and its relation to celiac disease. Am. J. Dis. Child. 56: 344-399, 1938.
5. ANDERSEN, D. H. AND R. G. HODGES. Celiac syndrome. V. Genetics of cystic fibrosis of the pancreas with a consideration of the etiology. Am. J. Dis. Child. 72: 62-80, 1946.
6. ANDERSON, M. P., H. A. BERGER, D. P. RICH, R. J. GREGORY, A. E. SMITH, AND M. J. WELSH. Nucleoside triphosphates are required to open the CFTR chloride channel. Cell 67: 775-784, 1991.
7. ANDERSON, M. P., R. J. GREGORY, S. THOMPSON, D. W. SOUZA, S. PAUL, R. C. MULLIGAN, A. E. SMITH, AND M. J. WELSH. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253: 202-205, 1991.
8. ANSAH, T. A. AND S. KATZ. Characterization of a plasma membrane enriched fraction of human skin fibroblasts derived from cystic fibrosis patients and age matched controls. Prof. W. Pharmacol. Soc. 23: 389-393, 1980.
9. ARVIDSSON, A., G. ALVAN, AND B. STRANDVIK. Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects. Acta Paediatr: Scand. 72: 293-294, 1983.
10. BANG, B. G. AND F. B. BANG. Mucus-stimulating substances in human body fluids assayed in an invertebrate mucous cell system. Johns Hopkins. Med. J. 145: 209-216, 1979.
11. BARASCH, J. AND Q. AL-AWQATI. Defective acidification of the biosynthetic pathway in cystic fibrosis. J. Cell Sci. 17, Suppl.: 229-233, 1993.
12. BARBERO, G. J. AND W. S. CHERNICK. The role of autonomic nervous system in cystic fibrosis. In: Research on Pathogenesis of Cystic Fibrosis, edited by P. A. DiSant'Agnese. Bethesda, MD: Natl. Inst. Arthritis Metabolic Dis., 1964, p. 208-225.
13. BARBERO, G. J. AND M. S. SIBINGA. Enlargement of the submaxillary salivary glands in cystic fibrosis. Pediatrics 29: 799-793, 1962.
14. - channels gating to an ATP hydrolysis cycle. Neuron 12: 473-482, 1994.
15. BAXTER, P., J. GOLDHILL, J. HARDCASTLE, P. T. HARDCASTLE, AND C. J. TAYLOR. Enhanced intestinal glucose and alanine transport in cystic fibrosis. Gut 31: 817-820, 1990.
16. BEAR, C. E., C. LI, N. KARTNER, R. J. BRIDGES, T. J. JENSEN, M. RAMJEESINGH, AND J. R. RIORDAN. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68: 809-818, 1992.
17. BEDROSSIAN, C. W., S. D. GREENBERG, D. B. SINGER, J. J. HANSEN, AND H. S. ROSENBERG. The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups. Hum. Pathol. 7: 195-204, 1976.
18. BEHM, J. K., G. HAGIWARA, N. L. LEWISTON, P. M. QUINTON, AND J. J. WINE. Hyposecretion of beta-adrenergically induced sweating in cystic fibrosis heterozygotes. Pediatr. Res. 22: 271-276, 1987.
19. BEN-YOSEPH, Y., P. REMBELSKI, AND H. L. NADLER. Correction of gamma-glutamyl transpeptidase deficiency in amniotic fluid of some cystic fibrosis fetuses by mixing with nondeficient fluids. Pediatr. Res. 18: 1340-1343, 1984.
20. BERSCHNEIDER, H. M., M. R. KNOWLES, R. G. AZIZKHAN, R. C. BOUCHER, N. A. TOBEY, R. C. ORLANDO, AND D. W. POWELL. Altered intestinal chloride transport in cystic fibrosis. FASEB J. 2: 2625-2629, 1988.
21. BIJMAN, J., W. DALEMANS, M. KANSEN, J. KEULEMANS, E. VERBEEK, A. HOOGEVEEN, H. DE JONGE, M. WILKE, D. DREYER, AND J. P. LECOCQ. Low-conductance chloride channels in IEC-6 and CF nasal cells expressing CFTR. Am. J. Physiol. 264 (Lung Cell. Mol. Physiol. 8): L229-L235, 1993.
22. BIJMAN, J. AND P. M. QUINTON. Apparent absence of cystic fibrosis sweat factor on ion selective and transport properties of the perfused human sweat duct. Pediatr. Res. 18: 1292-1296, 1984.
23. - impermeability on sweating in cystic fibrosis. Am. J. Physiol. 247 (Cell Physiol. 16): C3-C9, 1984.
24. BIJMAN, J., H. VEEZE, M. KANSEN, B. TILLY, B. SCHOLTE, A. HOOGEVEEN, D. HALLEY, M. SINAASAPPEL, AND H. DE JONGE. Chloride transport in the cystic fibrosis enterocyte. Adv. Exp. Med. Biol. 290: 287-294, 1991.
25. BIWERSI, J. AND A. S. VERKMAN. Functional CFTR in endosomal compartment of CFTR-expressing fibroblasts and T84 cells. Am. J. Physiol. 266 (Cell Physiol 35): C149-C156, 1994.
26. BLACKFAN, K. D. AND C. D. MAY. Inspissation of secretion, dilations of the ducts and acini, atrophy and fibrosis of the pancreas in infants. J. Pediatr. 13: 627-634, 1938.
27. BLOMFIELD, J., K. L. WARTON, AND J. M. BROWN. Flow rate and inorganic components of submandibular saliva in cystic fibrosis. Arch. Dis. Child. 48: 267-274, 1973.
28. BLUEBOND-LANGER, M. In the Shadow of Illness: Parents and Siblings of the Chronically Ill Child. Princeton, NJ: Princeton Univ. Press, 1996.
29. BOAT, T. F., P. W. CHENG, R. N. IYER, D. M. CARLSON, AND I. POLONY. Human respiratory tract secretions: mucous glycoproteins of nonpurulent tracheobronchial secretions, and sputum of patients with bronchitis and cystic fibrosis. Arch. Biochem. Biophys. 173: 528-537, 1976.
30. BOAT, T. F., U. N. WEISMAN, AND J. C. PALLAVICINI. Purification and properties of the calcium-precipitable protein in submaxillary saliva of normal and cystic fibrosis subjects. Pediatr. Res. 8: 531-539, 1974.
31. BODIAN, M. Fibrocystic Disease of the Pancreas: a Congenital Disorder of Mucus Production - Mucosis. New York: Grune & Stratton, 1953, p. 1-244.
32. BOTELHO, S. Y., A. M. GOLDSTEIN, AND M. L. ROSENLUND. Tear sodium, potassium, chloride, and calcium at various flow rates: children with cystic fibrosis and unaffected siblings without corneal staining. J. Pediatr. 83: 601-606, 1973.
33. BOUCHER, R. C. Human airway ion transport. Part two. Am. J. Respir. Crit. Care. Med. 150: 581-593, 1994.
34. BOWMAN, B. H., L. H. LOCKHART, AND M. L. MCCOMBS. Oyster ciliary inhibition by cystic fibrosis factor. Science 164: 325-326, 1969.
35. BRESLOW, J. L., J. EPSTEIN, J. H. FONTAINE, AND G. B. FORBES. Enhanced dexamethasone resistance in cystic fibrosis cells: potential use for heterozygote detection and prenatal diagnosis. Science 201: 180-182, 1978.
36. BRESLOW, J. L. AND J. MCPHERSON. Sodium transport in cystic-fibrosis-fibroblast not different from normal. N. Engl. J. Med. 305: 98, 1981.
37. BRESLOW, J. L., J. MCPHERSON, AND J. EPSTEIN. Distinguishing homozygous and heterozygous cystic fibrosis fibroblasts from normal cells by differences in sodium transport. N. Engl. J. Med. 304: 1-5, 1981.
38. BROCK, D. J., C. HAYWARD, AND M. SUPER. Controlled trial of serum isoelectric focusing in the detection of the cystic fibrosis gene. Hum. Genet. 60: 30-31, 1982.
39. BUSCH, R. Zur geschichte der mukoviszidose. Das Deutsche Gesundheitswesen 33: 316-320, 1978.
40. BUSCH, R. The history of Mucoviscidosis. NIH Lib. Trails. 53: 316-318, 1978.
41. BUSCH, R. Zur fruhgeschichte der zystischen pankreasfibromatose. NTM-Schriftenr. Gesch. Naturwiss 16: 95-109, 1979.
42. BUSCH, R. Die Mucoviscidose (Cystic fibrosis), Erkrankung mit bisher ungeklarter Struktur. Gegenbaurs. Morphol. Jahrb. 129: 459-465, 1983.
43. BUSCH, R. Historical aspects of cystic fibrosis. Wiss. Z. Univ. Rostok 35: 84-87, 1986.
44. BUSCH, R. Cystic fibrosis in the XIX century. Arch. Hist. Filoz. Med. 50: 427-434, 1987.
45. BUSCH, R. On the history of cystic fibrosis. Acta Univ. Carol. 36: 13-15, 1990.
46. CAGE, G. W., R. L. DOBSON, AND R. WALLER. Sweat gland function in cystic fibrosis. J. Clin. Invest. 45: 1373-1378, 1966.
47. CAREY, W. F. AND P. HOSLI. Inhibition of Tamm-Horsfall glycoprotein induction of alkaline phosphatase in cystic fibrosis fibroblasts by medium conditioned by normal cells. Aust. J. Exp. Biol. Med. Sci. 57: 225-230, 1979.
48. CEDER, O., P. HOSLI, E. VOGT, AND H. KOLLBERG. Diagnosis of cystic fibrosis homozygotes and heterozygotes from plasma and fibroblast cultures. A three-generation family study. Clin. Genet. 23: 298-303, 1983.
49. CEDER, O., G. M. ROOMANS, AND P. HOSLI. Increased calcium content in cultured fibroblasts from trisomy patients: comparison with cystic fibrosis fibroblasts. Scanning Electron Microsc. 2: 723-730, 1982.
50. CHACE, K. V., M. FLUX, AND G. P. SACHDEV. Comparison of physicochemical properties of purified mucus glycoproteins isolated from respiratory secretions of cystic fibrosis and asthamatic patients. Biochemistry 24: 7334-7341, 1985.
51. CHENG, P., T. BOAT, K. CRANFILL, J. YANKASKAS, AND R. C. BOUCHER. Increased sulfation of glycoconjugates by cultured CF nasal epithelial cells (Abstract). Pediatr. Pulmonol. 4 Suppl.: 130a, 1989.
52. CHENG, S. H., R. J. GREGORY, J. MARSHALL, S. PAUL, D. W. SOUZA, G. A. WHITE, C. R. O'RIORDAN, AND A. E. SMITH. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834, 1990.
53. CHERNICK, W. S. AND G. J. BARBERO. Reversal of submaxillary salivary alterations in cystic fibrosis by guanethidine. Mod. Probl. Pediatr. 10: 125-134, 1967.
54. CHERNICK, W. S., H. J. EICHEL, AND G. J. BARBERO. Submaxillary salivary enzymes as a measure of glandular activity in cystic fibrosis. J. Pediatr. 65: 694-700, 1964.
55. CHRISTOFFEL, K. S., J. D. LLOYD-STILL, G. BROWN, AND H. SHWACHMAN. Environmental deprivation and transient elevation of sweat electrolytes. J. Pediatr. 107: 231-234, 1985.
56. --secreting epithelial cells. Proc. Natl. Acad. Sci. USA 87: 4956-4960, 1990.
57. COHEN, L. H., P. A. DI SANTAGNESE, AND J. FRIEDLANDER. Cystic fibrosis and pregnancy: a national survey. Lancet 2: 842-844, 1980.
58. CONN, J. W. Aldosteronism in man: some clinical and climatological aspects. Part 1. JAMA 183: 775-781, 1963.
59. CONSTANTOPOULOS, S. H., E. V. TSIANOS, AND H. M. MOUTSOPOULOS. Pulmonary and gastrointestinal manifestations of Sjogren's syndrome. Rheum. Dis. Clin. North Am. 18: 617-635, 1992.
60. CRAWFORD, I., P. C. MALONEY, P. L. ZEITLIN, W. B. GUGGINO, S. C. HYDE, H. TURLEY, K. C. GATTER, A. HARRIS, AND C. F. HIGGINS. Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc. Natl. Acad. Sci. USA 88: 9262-9266, 1991.
61. DANES, B. S. AND A. G. BEARN. A genetic cell marker in cystic fibrosis of the pancreas. Lancet 18: 1061-1063, 1968.
62. DANES, B. S. AND A. G. BEARN. Cystic fibrosis of the pancreas. A study in cell culture. J. Exp. Med. 129: 775-793, 1969.
63. DANKS, D. M., J. ALLAN, AND C. M. ANDERSON. A genetic study of fibrocystic disease of the pancreas. Arch. Hum. Genet. 28: 323-340, 1965.
64. DAVIS, P. B., M. DRUMM, AND M. W. KONSTAN. Cystic fibrosis. Am. J. Respir. Crit. Care Med. 154: 1229-1256, 1996.
65. DAVIS, P. B., V. S. HUBBARD, AND P. A. DI SANT'AGNESE. Low sweat electrolytes in a patient with cystic fibrosis. Am. J. Med. 69: 643-646, 1980.
66. DENNING, G. M., M. P. ANDERSON, J. F. AMARA, J. MARSHALL, A. E. SMITH, AND M. J. WELSH. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358: 761-764, 1992.
67. DIMAGNO, E. P., J. R. MALAGELADA, AND V. L. M. GO. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two dosage schedules. N. Engl. J. Med. 296: 1318-1322, 1977.
68. DI SANT'AGNESE, P. A. Cystic fibrosis of the pancreas. Am. J. Med. 21: 406-422, 1956.
69. DI SANT'AGNESE, P. A. Seminar on diseases of the pancreas: cystic fibrosis of the pancreas. Am. J. Med. 21: 406-422, 1956.
70. DI SANT'AGNESE, P. A. AND W. A. BLANC. A distinctive type of biliary cirrhosis of the liver associated with cystic fibroiss of the pancreas. Pediatrics 18: 387-409, 1956.
71. DI SANT'AGNESE, P. A., R. C. DARLING, G. A. PERERA, AND E. SHEA. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas. Pediatrics 12: 549-563, 1953.
72. DI SANT'AGNESE, P. A., H. GROSSMAN, R. C. DARLING, AND C. R. DENNING. Saliva, tears and duodenal contents in cystic fibrosis of the pancreas. Pediatrics 22: 507-514, 1958.
73. DI SANT'AGNESE, P. A. AND V. S. HUBBARD. The intestinal tract. In: Cystic Fibrosis, edited by L. M. Taussig. New York: Thieme-Stratton, 1984, p. 212-229.
74. DI SANT'AGNESE, P. A. AND G. F. POWELL. The eccrine sweat defect in cystic fibrosis of the pancreas (mucoviscidosis). Ann. NY Acad. Sci. 93: 555-599, 1962.
75. DI SANT'AGNESE, P. A., AND R. C. TALAMO. Pathogenesis on physiolopathology of cystic fibrosis of the pancreas. N. Engl. J. Med. 277: 1287-1295, 1967.
76. DI SANT'AGNESE, P. A., R. C. TALAMO, R. J. GRAND, AND J. C. PALLAVICINI. Effect of aldosterone on normal subjects and patients with cystic fibrosis. In: Research on Pathenogenesis of Cystic Fibrosis, edited by P. A. DiSant'Agnese. Bethesda, MD: NIA, 1964, p. 189-201.
77. DISCHE, Z., P. A. DI SANT'AGNESE, J. C. PALLAVICINI, AND J. YOULOS. Composition of mucoprotein fractions from duodenal fluid of patients with cystic fibrosis of the pancreas and from controls. Pediatrics 24: 74-91, 1959.
78. DOBSON, R. L. Sweat sodium excretion in normal men, women, and children. In: Modern Problems in Pediatrics, edited by E. Rossi and E. Stoll. Basel: Karger, 1967, vol. 10, p. 23-31.
79. DOBSON, R. L. The effect of repeated episodes of profuse sweating on the human eccrine sweat glands. J. Invest. Dermatot. 35: 195-198, 1968.
80. DOBSON, R. L. AND G. W. CAGE. The eccrine sweat gland in systemic disease. Pathogenesis Cystic Fibrosis 57-66, 1966.
81. DOGGETT, R. G. AND G. M. HARRISON. Cystic fibrosis: reversal of ciliary inhibition in serum and saliva by heparin. Tex. Rep. Biol. Med. 31: 685-689, 1973.
82. DOGGETT, R. G., G. M. HARRISON, AND R. E. CARTER. Mucoid Pseudomonas aeruginosa in patients with chronic illnesses. Lancet 1: 236-237, 1971.
83. DOGGETT, R. G., G. M. HARRISON, AND E. WALLIS. Comparison of some properties of Pseudomonas aeruginosa isolated from infections in persons with and without cystic fibrosis. J. Bacteriol. 87: 427-431, 1964.
84. DOOLEY, R. R., H. BRAUNSTEIN, AND A. B. OSHER. Polypoid cervicitis in cystic fibrosis patients receiving oral contraceptives. Am. J. Obstet. Gynecol. 118: 971-974, 1974.
85. DRUMM, M. L., H. A. POPE, W. H. CLIFF, J. M. ROMMENS, S. A. MARVIN, L. C. TSUI, F. S. COLLINS, R. A. FRIZZELL, AND J. M. WILSON. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 62: 1227-1233, 1990.
86. DRUMM, M. L., D. J. WILKINSON, L. S. SMIT, R. T. WORRELL, T. V. STRONG, R. A. FRIZZELL, D. C. DAWSON, AND F. S. COLLINS. Chloride conductance expressed by ΔF508 and other mutant CFTRs in Xenopus oocytes. Science 254: 1797-1799, 1991.
87. EIBERG, H., J. MOHR, K. SCHMIEGELOW, L. S. NIELSEN, AND R. WILLIAMSON. Linkage relationships of paraoxonasse (PON) with other genetic markers: indication of cystic fibrosis synteny. Clin. Genet. 28: 265-271, 1985.
88. EMRICH, H. M., E. STOLLE, B. FRIOLET, J. P. COLOMBO, E. ROSSI, AND R. RICHTERICH. Excretion of different substances in the sweat of children with cystic fibrosis and controls. In: Modern Problems in Pediatrics. X. Cystic Fibrosis, edited by E. Rossi and E. Stoll. Basel: Karger, 1967, p. 58-73.
89. EMRICH, H. M., E. STOLLE, B. FRIOLET, E. ROSSI, AND R. RICHTERICH. Sweat composition in relation to rate of sweating in patients with cystic fibrosis of the pancreas. Pediatr. Res. 2: 464-478, 1968.
90. ESTERLY, J. R. AND E. H. OPPENHEIMER. Observations in cystic fibrosis of the pancreas. I. The gall bladder. Johns Hopkins Hosp. Bull. 10: 247-254, 1962.
91. ESTERLY, J. R., AND E. H. OPPENHEIMER. Observations in cystic fibrosis of the pancreas. III. Pulmonary lesions. John Hopkins Med. J. 122: 94-101, 1967.
92. ESTERLY, J. R., AND E. H. OPPENHEIMER. Cystic fibrosis of the pancreas: structural changes in the peripheral airways. Thorax 23: 670-675, 1968.
93. FANCONI, G., E. UEHLINGER, AND C. KNAUER. Das coeliakiesyndrom bei angeborener zysticher pankreasfibromatose und bronchiectasien. Wiener Klin. Wochen. 86: 753, 1936.
94. FARBER, S. Some organic digestive disturbances in early life. J. Mich. State. Med. Soc. 44: 587-594, 1945.
95. FINKELSTEIN, E. AND K. HALL. Aminoglycoside clearance in patients with cystic fibrosis. J. Pediatr. 94: 163-164, 1979.
96. FITZSIMMONS, S. C. Cystic Fibrosis Foundation Patient Registry 1996 Annual Data Report. Bethesda, MD: Cystic Fibrosis Found., 1997, p. 1-51.
97. FORSTNER, G., G. GALL, AND M. COREY. Digestion and absorption of nutrients in cystic fibrosis. In: Perspectives in Cystic Fibrosis, edited by J. M. Sturgess. Toronto: Imperial, 1980, p. 137-148.
98. FRASE, L. L., A. D. STRICKLAND, G. W. KACHEL, AND G. J. KREJS. Enhanced glucose absorption in the jejunum of patients with cystic fibrosis. Gastroenterology 88: 478-484, 1985.
99. FRIZZELL, R. A., G. RECHKEMMER, AND R. L. SHOEMAKER. Altered regulation of airway epithelial cell chloride channels in cystic fibrosis. Science 233: 558-560, 1986.
100. GABRIEL, S. E., K. N. BRIGMAN, B. H. KOLLER, R. C. BOUCHER, AND M. J. STUTTS. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266: 107-109, 1994.
101. GARROD, A. E., AND W. H. HURTLEY. Congenital family steatorrhoea. Q. J. Med. 6: 242-258, 1912.
102. GIBSON, L. E., AND R. E. COOKE. A test for the concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23: 545-549, 1959.
103. GIBSON, L. E. AND P. A. DI SANT'AGNESE. Studies of salt excretion in sweat. J. Pediatr. 62: 855-867, 1963.
104. GILBERT, J., J. KELLEHER, J. M. LITTLEWOOD, AND D. F. EVANS. Ileal pH in cystic fibrosis. Scand. J. Gastroenterol Suppl. 143: 132-134, 1988.
105. GOLDMAN, M. J., G. M. ANDERSON, E. D. STOLZENBERG, U. P. KARI, M. ZASLOF, AND J. M. WILSON. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88: 553-560, 1997.
106. - secretion is absent in cystic fibrosis. Gastroenterology 107: 950-956, 1994.
107. GRAY, M. A., A. HARRIS, L. COLEMAN, J. R. GREENWELL, AND B. E. ARGENT. Two types of chloride channel on duct cells cultured from human fetal pancreas. Am. J. Physiol. 257 (Cell Physiol. 26): C240-C251, 1989.
108. GREGORY, P. C. Gastrointestinal pH, motility/transit and permeability in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 23: 513-523, 1996.
109. GREGORY, R. J., S. H. CHENG, D. P. RICH, J. MARSHALL, S. PAUL, K. HEHIR, L. OSTEDGAARD, K. W. KLINGER, M. J. WELSH, AND A. E. SMITH. Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature 347: 382-386, 1990.
110. GUGGINO, W. B. AND P. M. QUINTON. Comparative pathologies of CF and other respiratory diseases. Pediatr. Pulmonol. 13, Suppl.: 173-184, 1996.
111. GUNDERSON, K. L., AND R. R. KOPITO. Conformational states of CFTR associated with channel gating: the role of ATP binding and hydrolysis. Cell 82: 231-239, 1995.
112. GUPTA, R., AND N. JENTOFT. The structure of tracheobronchial mucins from cystic fibrosis and control patients. J. Biol. Chem. 267: 3160-3167, 1992.
113. HADORN, B., P. G. JOHANSEN, AND C. M. ANDERSON. Pancreozymin secretin test of exocrine pancreatic function in cystic fibrosis and the significance of the result for the pathogenesis of the disease. Can. Med. J. 98: 377-384, 1968.
114. HADORN, B., G. ZOPPI, D. H. SHMERLING, A. PRADER, I. MCINTYRE, AND C. M. ANDERSON. Quantitative assessment of exocrine pancreatic function in infants and children. J. Pediatr. 73: 39-50, 1968.
115. HANUKOGLU, A., T. BISTRITZER, Y. RAKOVER, AND A. MANDELBERG. Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. J. Pediatr. 125: 752-755, 1994.
116. HARDCASTLE, J., C. J. TAYLOR, P. T. HARDCASTLE, P. S. BAXTER, AND J. GOLDHILL. Intestinal transport in cystic fibrosis (CF). Acta Univ. Carol. 36: 157-158, 1990.
117. HARPER, M. H. Congenital steatorrhoea due to pancreatic defect. Arch. Dis. Child. 13: 45-56, 1938.
118. HAWS, C., M. E. KROUSE, Y. XIA, D. C. GRUENERT, AND J. J. WINE. CFTR channels in immortalized human airway cells. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L692-L707, 1992.
119. HEDMAN, A., G. ALVAN, B. STRANDVIK, AND A. ARVIDSSON. Increased renal clearance of cefsulodin due to higher glomerular nitration rate in cystic fibrosis. Clin. Pharmacokinetics 18: 168-175, 1990.
120. - conductance. FEBS Lett. 374: 312-316, 1995.
121. HOLSCLAW, D. S., A. D. PERELMUTTTER, H. JOCKIN, AND H. SHWACHMAN. Genital abnormalities in males with cystic fibrosis: an emerging problem. J. Urol. 106: 568-574, 1971.
122. HOME, E. On the formation of fat in the intestines of living animals. Proc. R. Soc. Lond. Philos. Trans. 103: 146-158, 1813.
123. JOHANSEN, P. G., C. M. ANDERSON, AND B. HADORN. Cystic fibrosis of the pancreas: a generalized disturbance of water and electrolyte movement in exocrine tissues. Lancet 2: 455-460, 1968.
124. JOHNSTON, C., K. BUCHANAN, C. SHAW, AND A. REDMOND. Vasoactive intestinal peptide and abnormal mucus accumulation in the small bowel of patients with cystic fibrosis. In: Perspectives in Cystic Fibrosis: Proceedings of the Eigth Annual Congress on Cystic Fibrosis, edited by J. Sturgess. Mississauga, Canada: Canadian Cystic Fibrosis Foundation, 1980, p. 97-101.
125. JORIS, L., I. DAB, AND P. M. QUINTON. Elemental composition of human airway surface fluid in healthy and diseased airways. Am. Rev. Respir. Dis. 148: 1633-1637, 1993.
126. JUSKO, W. J., L. L. MOSOVICH, L. M. GERBRACHT, M. E. MATTAR, AND S. J. YAFFE. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics 56: 1038-1044, 1975.
127. KAPLAN, E., H. SHWACHMAN, A. D. PERLMUTTER, A. RULE, K. T. KHAW, AND D. S. HOLSCLAW. Reproductive failure in males with cystic fibrosis. N. Engl. J. Med. 279: 65-69, 1968.
128. KARTNER, N., O. AUGUSTINAS, T. J. JENSEN, A. L. NAISMITH, AND J. R. RIORDAN. Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland. Nature Genet. 1: 321-327, 1992.
129. KARTNER, N., J. W. HANRAHAN, T. J. JENSEN, A. L. NAISMITH, S. SUN, C. A. ACKERLEY, E. F. REYES, L. C. TSUI, J. M. ROMMENS, C. E. BEAR, AND J. R. RIORDAN. Expression of the cystic fibrosis gene in non-epithelial cells produces a regulated anion conductance. Cell 64: 681-691, 1991.
130. 2+)-ATPase activity in erythrocyte membranes of cystic fibrosis patients and controls. Cell Calcium 2: 545-552, 1981.
131. KENT, G., R. ILES, C. E. BEAR, L. J. HUAN, U. GRIESENBACH, C. MCKERLIE, H. FRNDOVA, C. ACKERLEY, D. GOSSELIN, D. RADZIOCH, H. O'BRODOVICH, L. C. TSUI, M. BUCHWALD, AND A. K. TANSWELL. Lung disease in mice with cystic fibrosis. J. Clin. Invest. 100: 3060-3069, 1997.
132. KEREM, B. S., J. M. ROMMENS, J. A. BUCHANAN, D. MARKIEWICZ, T. K. COX, A. CHAKRAVARTI, M. BUCHWALD, AND L. C. TSUI. Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073-1080, 1989.
133. KEREM, E., M. COREY, B. S. KEREM, J. ROMMENS, D. MARKIEWICZ, H. LEVISON, L. C. TSUI, AND P. DURIE. The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (delta F508). N. Engl. J. Med. 323: 1517-1522, 1990.
134. KESSLER, W. R. AND D. H. ANDERSEN. Heat prostration in fibrocystic disease of the pancreas and other conditions. Pediatrics 8: 648-655, 1951.
135. KHAN, T. Z., J. S. WAGENER, T. BOST, J. MARTINEZ, F. J. ACCURSO, AND D. W. RICHES. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151: 1075-1082, 1995.
136. KILBOURN, J. P. Bacterial content and ionic composition of sputum in cystic fibrosis. Lancet 1: 334, 1978.
137. KILBOURN, J. P. Composition of sputum from patients with cystic fibrosis. Curr. Opin. Neurobiol. 11: 19-22, 1984.
138. KIRCHNER, K. K., J. S. WAGENER, T. Z. KHAN, S. C. COPENHAVER, AND F. J. ACCURSO. Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 154: 1426-1429, 1996.
139. KNOWLES, M., J. GATZY, AND R. C. BOUCHER. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 305: 1489-1495, 1981.
140. KNOWLES, M. R., J. L. CARSON, A. M. COLLIER, J. T. GATZY, AND R. C. BOUCHER. Measurements of nasal transepithelial electric-potential differences in normal human subjects in vivo. Am. Rev. Respir. Dis. 124: 484-490, 1981.
141. KNOWLES, M. R., J. GATZY, AND R. C. BOUCHER. Relative ion permeability of normal and cystic fibrosis nasal epithelium. J. Clin. Invest. 71: 1410-1417, 1983.
142. KNOWLES, M. R., J. M. ROBINSON, R. E. WOOD, C. A. PUE, W. M. MENTZ, G. C. WAGER, J. T. GATZY, AND R. C. BOUCHER. Ion composition of airway surface liquid in patients with cystic fibrosis as compared with normal and disease-control subjects. J. Clin. Invest. 100: 2588-2595, 1997.
143. KNOWLES, M. R., M. J. STUTTS, A. SPOCK, N. FISCHER, J. T. GATZY, AND R. C. BOUCHER. Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 221: 1067-1070, 1983.
144. KNOWLES, M. R., M. J. STUTTS, J. R. YANKASKAS, J. T. GATZY, AND R. C. BOUCHER. Abnormal respiratory epithelial ion transport in cystic fibrosis. Clin. Chest Med. 7: 285-297, 1986.
145. KNOWLTON, R. G., O. C. COHEN-HAGUENAUER, V. C. NGUYEN, J. FREZAL, V. A. BROWN, D. BARKER, J. C. BRAMAN, J. W. SCHUMM, L. C. TSUI, M. BUCHWALD, AND H. DONNIS-KELLER. A polymorphic DNA marker linked to cystic fibrosis is located on chromosome 7. Nature 318: 380-382, 1985.
146. KNUDSON, A. G., L. WAYNE, AND W. Y. HALLETT. On the selective advantage of cystic fibrosis heterozygotes. Am. J. Hum. Genet. 19: 388-392, 1967.
147. KOPELMAN, H., M. COREY, K. GASKIN, P. DURIE, Z. WEIZMAN, AND G. FORSTNER. Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology 95: 349-355, 1988.
148. KOPELMAN, H., P. DURIE, K. GASKIN, Z. WEIZMAN, AND G. FORSTNER. Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. N. Engl. J. Med. 312: 329-334, 1985.
149. KOPITO, L. E., H. J. KOSASKY, AND H. SHWACHMAN. Water and electrolytes in cervical mucus from patients with cystic fibrosis. Fertil. Steril. 24: 512-516, 1973.
150. KOPITO, L. E., AND H. SHWACHMAN. The pancreas in cystic fibrosis: chemical composition and comparative morphology. Pediatr. Res. 10: 742-749, 1976.
151. KRISTIDIS, P., D. BOZON, M. COREY, D. MARKIEWICZ, J. ROMMENS, L. C. TSUI, AND P. DURIE. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am. J. Hum. Genet. 50: 1178-1184, 1992.
152. KUNZELMANN, K., H. PAVENSTADT, AND R. GREGER. Properties and regulation of chloride channels in cystic fibrosis and normal airway cells. Pflügers Arch. 415: 172-182, 1989.
153. LAMB, D., AND L. REID. The tracheobronchial submucosal glands in cystic fibrosis: a qualitative and quantitative histochemical study. Br. J. Dis. Chest 66: 239-247, 1972.
154. LANDING, B. H., T. R. WELLS, AND C. I. WANG. Abnormality of the edipidymus and vas deferens in cystic fibrosis. Arch. Pathol. 88: 239-247, 1969.
155. LANDSTEINER, K. Darmverschluss durch eingedicktes Meconium. Pankreatitis. Centr. Allg. Pathol. 16: 903-907, 1905.
156. LEEDER, J. S., M. SPINO, A. F. ISLES, A. M. TESORO, R. GOLD, AND S. M. MACLEOD. Ceftazidime disposition in acute and stable cystic fibrosis. Clin. Pharmacol. Ther. 36: 355-362, 1984.
157. LEGRYS, V. A., M. F. BURRITT, L. E. GIBSON, K. B. HAMMOND, K. KRAFT, AND B. J. ROSENSTEIN. Sweat Testing: Guide to Sample Collection and Quantitative Analysis - Approved Guide, NCCLS Document C34-A. Villanova, PA: National Committe on Clinical Laboratory Standards, 1994, p. 1-45.
158. LETHEM, M. I., S. L. JAMES, AND C. MARRIOTT. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum. Am. Rev. Respir. Dis. 142: 1053-1058, 1990.
159. - conductance is lacking in cystic fibrosis mice epididymides and seminal vesicles. Am. J. Physiol. 271 (Cell Physiol. 40): C188-C193, 1996.
160. LEV, R. AND S. S. SPICER. A histochemical comparison of human epithelial mucins in normal and in hypersecretory states including pancreatic cystic fibrosis. Am. J. Pathol. 46: 23-47, 1965.
161. LI, C., M. RAMJEESINGH, E. REYES, T. JENSEN, X. CHANG, J. M. ROMMENS, AND C. E. BEAR. The cystic fibrosis mutation (DeltaF508) does not influence the chloride channel activity of CFTR. Nature Genet. 3: 311-316, 1993.
162. LIEBERMAN, J., W. KANESHIRO, AND N. V. COSTEA. Presence of a serum hemagglutinin (lectinlike factor) in cystic fibrosis homozygotes and heterozygotes. J. Lab. Clin. Med. 97: 646-653, 1981.
163. LIEBERMAN, J., AND K. H. TACHIKI. Effect of menses, estrogens and hemolysis on a serum-lectin-like factor in cystic fibrosis. Chest 95: 111-116, 1989.
164. LIN, S. Y., G. L. AMIDON, N. D. WEINER, AND A. H. GOLDBERG. Viscoelasticity of anionic polymers and their mucociliary transport on the frog palate. Pharm. Res. 10: 411-417, 1993.
165. LIST, S. J., B. P. FINDLAY, G. G. FORSTNER, AND J. F. FORSTNER. Enhancement of the viscosity of mucin by serum albumin. Biochem. J. 175: 565-571, 1978.
166. LOBECK, C. C., AND N. MCSHERRY. Response of sweat electrolyte concentrations to 9 alpha-fluorohydrocortisone in patients with cystic fibrosis and their families. J. Pediatr. 62: 393-398, 1963.
167. LOBECK, C. C., AND N. R. MCSHERRY. The ionic composition of pilocarpine induced sweat in relation to gland output during aging and cystic fibrosis. In: Modern Problems in Pediatrics, edited by E. Rossi and E. Stoll. Basel: Karger, 1967, p. 41-53.
168. MANDEL, I. D., A. ERIV, A. KUTSCHER, C. DENNING, R. THOMPSON, W. KESSLER, AND E. ZEGARELLI. Calcium and phosphorus levels in submaxillary saliva. Clin. Pediatr. 8: 161-164, 1969.
169. MANDEL, I. D., A. KUTSCHER, C. R. DENNING, R. H. THOMPSON, AND E. V. ZEGARELLI. Salivary studies in cystic fibrosis. Am. J. Dis. Child. 113: 431-438, 1967.
170. MANGOS, J. A., AND N. MCSHERRY. Sodium transport: inhibitory factor in sweat of patients with cystic fibrosis. Science, 158: 135-136, 1967.
171. MANGOS, J. A., AND N. R. MCSHERRY. Studies on the mechanism of inhibition of sodium transport in cystic fibrosis of the pancreas. Pediatr. Res. 2: 378-384, 1968.
172. MANGOS, J. A., N. R. MCSHERRY, AND P. J. BENKE. A sodium transport inhibitory factor in the saliva of patients with cystic flbrosis of the pancreas. Pediatr. Res. 1: 436-442, 1967.
173. MASTELLA, G., G. BARBATO, AND C. TRABUCCHI. II pancreas esocrino nella fibrosi cistica: indagine funzionale su 169 pazienti e 118 controlli. Riv. Ital. Pediatr. 1: 109-130, 1975.
174. MATTES, P. M., P. C. MALONEY, AND J. W. LITTLEFIELD. Altered chloride metabolism in cultured cystic fibrosis skin fibroblasts. Proc. Natl. Acad. Sci. USA 84: 3009-3013, 1987.
175. MATTHEWS, L. W., S. SPECTOR, J. LEMM, AND J. L. POTTER. Studies on pulmonary secretions. I. The over-all chemical composition of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am. Rev. Respir. Dis. 88: 199-204, 1963.
176. MICHALSEN, H., E. MONN, T. BERGAN, J. CHURG, AND J. V. JOHANNESSEN. Renal biopsies in cystic fibrosis. Pathol. Res. Pract. 178: 261-267, 1984.
177. MORALES, M. M., T. P. CARROLL, T. MORITA, E. M. SCHWIEBERT, O. DEVUYST, P. D. WILSON, A. G. LOPES, B. A. STANTON, H. C. DIETZ, G. R. CUTTING, AND W. B. GUGGINO. Both the wild type and a functional isoform of CFTR are expressed in kidney. Am. J. Physiol. 270 (Renal Physiol. 39): F1038-F1048, 1996.
178. NEUTRA, M. R., AND J. S. TRIER. Rectal mucosa in cystic fibrosis: morphological features before and after short term organ culture. Gastroenterology 75: 701-710, 1978.
179. O'LOUGHLIN, E. V., D. M. HUNT, K. J. GASKIN, D. STIEL, I. M. BRUZUSZCAK, H. C. MARTIN, C. BAMBACH, AND R. SMITH. Abnormal epithelial transport in cystic fibrosis jejunum. Am. J. Physiol. 260 (Gastrointest. Liver Physiol. 23): G758-G763, 1991.
180. OPPENHEIMER, E. H., AND J. R. ESTERLY. Observations on cystic fibrosis of the pancreas. V. Developmental changes in the male genital system. J. Pediatr. 75: 806-811, 1969.
181. OPPENHEIMER, E. H., AND J. R. ESTERLY. Observations on cystic fibrosis of the pancreas. VI. The uterine cervix. J. Pediatr. 77: 991-995, 1970.
182. OPPENHEIMER, E. H., AND J. R. ESTERLY. Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases. Perspect. Pediatr. Pathol. 2: 241-278, 1975.
183. POTTER, J. L., L. W. MATTHEWS, J. LEMM, AND S. SPECTOR. Human pulmonary secretions in health and disease. Ann. NY Acad. Sci. 106: 692-697, 1963.
184. POTTER, J. L., L. W. MATTHEWS, S. SPECTOR, AND J. LEMM. Studies on pulmonary secretions. II. Osmolality and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am. Rev. Respir. Dis. 96: 83-87, 1967.
185. POTTER, J. L., S. SPECTOR, L. W. MATTHEWS, AND J. LEMM. Studies on pulmonary secretions. III. The nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am. Rev. Respir. Dis. 99: 909-916, 1969.
186. PRITCHARD, D. J., G. R. HICKMAN, AND R. NELSON. Sex ratio and heterozygote advantage in cystic fibrosis families. Arch. Dis. Child. 58: 290-293, 1983.
187. PUCHELLE, E., J. M. ZAHM, S. DE BENTZMANN, C. GROSSKOPF, S. SHAK, D. MOUGEL, AND J. M. POLU. Effects of rhDNase on purulent airway secretions in chronic bronchitis. Eur. Respir. J. 9: 765-769, 1996.
188. QUINTON, P. M. Water metabolism: protozoa to man. In: Comparative Animal Nutrition, edited by M. Recighl. Basel: Karger, 1979, p. 100-231.
189. QUINTON, P. M. Suggestion of an abnormal anion exchange mechanism in sweat glands of cystic fibrosis patients. Pediatr. Res. 16: 533-537, 1982.
190. QUINTON, P. M. Abnormalities in electrolyte secretion in cystic fibrosis. In: Fluid and Electrolyte Abnormalities in Cystic Fibrosis, edited by P. M. Quinton, R. M. Martinez, and U. Hopfer. San Francisco, CA: San Francisco Press, 1982, p. 53-76.
191. QUINTON, P. M. Chloride impermeability in cystic fibrosis. Nature 301: 421-422, 1983.
192. QUINTON, P. M. Exocrine Glands, edited by L. M. Taussig. New York: Thieme-Stratton, 1984, p. 338-375.
193. QUINTON, P. M. Cystic fibrosis: a disease in electrolyte transport. FASEB J. 4: 2709-2717, 1990.
194. QUINTON, P. M. Viscosity versus composition in airway pathology. Am. J. Respir. Crit. Care Med. 149: 6-7, 1994.
195. QUINTON, P. M. What is good about cystic fibrosis? Curr. Biol. 4: 742-743, 1994.
196. QUINTON, P. M., AND J. BIJMAN. Higher bioelectric potentials due to decreased chloride absorption in the sweat glands of patients with cystic fibrosis. N. Engl. J. Med. 308: 1185-1189, 1983.
197. QUINTON, P. M., AND M. M. REDDY. Regulation of absorption in the human sweat duct. Adv. Exp. Med. Biol. 290: 159-172, 1991.
198. QUINTON, P. M., AND M. M. REDDY. Control of CFTR Cl conductance by ATP levels through non-hydrolytic binding. Nature 360: 79-81, 1993.
199. RAMSEY, B., S. J. ASTLEY, M. L. AITKEN, W. BURKE, A. COLIN, H. DORKIN, J. D. EISENBERG, R. L. GIBSON, I. R. HARWOOD, D. V. SCHIDLOW, R. W. WILMOTT, M. E. WOHL, L. J. MEYERSON, S. SHAK, H. FUCHS, AND A. L. SMITH. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am. Rev. Respir. Dis. 148: 145-151, 1993.
200. RAO, G. J., AND H. L. NADLER. Deficiency of arginine esterase in cystic fibrosis of the pancreas: demonstration of the proteolytic nature of the activity. Pediatr. Res. 9: 739-741, 1975.
201. RAO, G. J., M. W. PLATT, AND H. L. NADLER. Reaction of 4-methylumbelliferylguanidinobenzoate with proteases in plasma of patients with cystic fibrosis. Enzyme 23: 314-319, 1978.
202. RAO, G. J., G. SPELLS, AND H. L. NADLER. Enhanced UDP-galactose: glycoprotein galactosyl transferase activity in cultivated skin fibroblasts from patients with cystic fibrosis and its possible relationship to the pathogenesis of the disease. Pediatr. Res. 11: 981-985, 1977.
203. - conductance. Am. J. Physiol 271 (Cell Physiol. 40): C35-C42, 1996.
204. REDDY, M. M., J. R. RIORDAN, AND P. M. QUINTON. Electrical properties of cultured reabsorptive sweat duct cells from normal and cystic fibrosis subjects: intracellular microelectrode analysis. In: Cellular and Molecular Basis of Cystic Fibrosis, edited by G. Mastella and P. M. Quinton. San Francisco, CA: San Francisco Press, 1988, p. 383-394.
205. REID, L., AND R. DE HALLER. The bronchial mucous glands-their hypertrophy and change in intracellular mucus. Mod. Prob. Pediatr. 10: 195-199, 1967.
206. RICH, D. P., M. P. ANDERSON, R. J. GREGORY, S. H. CHENG, S. PAUL, D. M. JEFFERSON, J. D. MCCANN, K. W. KLINGER, A. E. SMITH, AND M. J. WELSH. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 347: 358-363, 1990.
207. RIORDAN, J. R., N. ALON, AND M. BUCHWALD. Plasma membrane lipids of human diploid fibroblasts from normal individuals and patients with cystic fibrosis. Biochim. Biophys. Acta 574: 39-47, 1979.
208. RIORDAN, J. R., J. M. ROMMENS, B. S. KEREM, N. ALON, R. ROZMAHEL, Z. GRZELCZAK, J. ZELENSKI, S. LOK, N. PLAVSIC, J. L. CHOU, M. L. DRUMM, M. C. IANNUZZI, F. S. COLLINS, AND L. C. TSUI. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1072, 1989.
209. ROBINSON, P. J., A. L. SMITH, AND P. D. SLY. Duodenal pH in cystic fibrosis and its relationship to fat malabsorption. Dig. Dis. Sci. 35: 1299-1304, 1990.
210. ROBSON, A. M., S. TATEISHI, J. R. INGELFINGER, D. B. STROMINGER, AND S. KLAHR. Renal function in patients with cystic fibrosis. J. Pediatr. 79: 42-50, 1971.
211. ROKITANSKY, C. von Handbuch der speciellen pathologischen Anatomie, II. Vienna: Braumuller & Seidel, 1842.
212. ROMMENS, J. M., S. DHO, C. E. BEAR, N. KARTNER, D. KENNEDY, J. R. RIORDAN, L.-C. TSUI, AND J. K. FOSKETT. cAMP-inducible chloride conductance in mouse fibroblast lines stably expressing the human cystic fibrosis transmembrane conductance regulator. Proc. Natl. Acad. Sci. USA 22: 7500-7504, 1991.
213. ROMMENS, J. M., M. C. IANNUZZI, B. S. KEREM, M. L. DRUMM, G. MELMER, M. DEAN, R. ROZMAHEL, J. L. COLE, D. KENNEDY, N. HIDAKA, M. ZSIGA, M. BUCHWALD, J. R. RIORDAN, L. C. TSUI, AND F. S. COLLINS. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059-1065, 1989.
214. ROSENSTEIN, B. J., AND T. S. LANGBAUM. Diagnosis. In: Cystic Fibrosis, edited by L. M. Taussig. New York: Thieme-Stratton, 1984, p. 85-114.
215. SATO, K., AND F. SATO. Defective beta adrenergic response of cystic fibrosis sweat glands in vivo and in vitro. J. Clin. Invest. 73: 1763-1771, 1984.
216. SATO, K., AND F. SATO. Variable reduction in β-adrenergic sweat secretion in cystic fibrosis heterozygotes. J. Lab. Clin. Med. 111: 511-518, 1988.
217. SBARBATI, A., M. BERTINI, C. CATASSI, R. GAGLIARDINI, AND F. OSCULATI. Ultrastructural lesions in the small bowel of patients with cystic fibrosis. Pediatr. Res. 43: 234-239, 1998.
218. SCHARFMAN, A., E. VAN BRUSSEL, N. HOUDRET, G. LAMBLIN, AND P. ROUSSEL Interactions between glycoconjugates from human respiratory airways and Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med. 154, Suppl.: S163-S169, 1996.
219. SCHIDLOW, D. V. Primary ciliary dyskinesia (the immotile cilia syndrome). Ann. Allergy 73: 457-468, 1994.
220. SCHNEYER, C. A. Salivary gland changes after isoproterenol-induced enlargement. Am. J. Physiol. 203: 232-236, 1962.
221. SCHONI, M. H., F. SCHONI-AFFOLTER, D. JEFFERY, AND S. KATZ. Intracellular free calcium levels in mononuclear cells of patients with cystic fibrosis and normal controls. Cell Calcium 8: 53-63, 1987.
222. SCHULZ, I. Micropuncture studies of the sweat formation in cystic fibrosis patients. J. Clin. Invest. 48: 1470-1477, 1969.
223. SCHULZ, I. J., AND E. FROMTER. Mikopunktionsuntersuchungen an schweibdrusen von mucoviscidosepatienten und gesunden Versuchspersonen. In: Mucoviscidose/Cystische Fibrose, edited by A. Windorfer and U. Stephan. Stuttgart: Georg Thieme Verlag, 1968, p. 12-21.
224. SCHULZ, I. J., K. J. ULLRICH, E. FROMTER, H. HOLZGREVE, A. FRICK, AND U. HEGEI. Mikropunction und elektrische potentialmessung an schweibdrusen des menschen. Eur. J. Physiol. 284: 360-372, 1965.
225. SCHWARTZ, I. L., J. H. THAYSEN, AND V. P. DOLE. Sodium and potassium excretion in human sweat. Am. J. Physiol. 179: 671, 1954.
226. SCHWARZ, V., AND C. H. SUTCLIFFE. The effect of some ions and drugs on sweat secretion. In: Modern Problems in Pediatrics, edited by E. Rossi and E. Stoll. Basel: Karger, 1967, vol. 10, p. 89-94.
227. SEKSEK, O., J. BIWERSI, AND A. S. VERKMAN. Evidence against defective trans-Golgi acidification in cystic fibrosis. J. Biol. Chem. 271: 15542-15548, 1996.
228. SELYE, H., R. VEILLEUX, AND M. CANTIN. Excessive stimulation of salivary gland growth by isoproterenol. Science 133: 44-45, 1961.
229. SHACKELFORD, J. M., AND H. P. BENTLEY. Carbohydrate histochemistry of the salivary glands and pancreas in cystic fibrosis. J. Histochem. Cytochem. 12: 512-521, 1963.
230. SHAH, P. L., S. F. SCOTT, R. A. KNIGHT, C. MARRIOTT, C. RANASINHA, AND M. E. HODSON. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. Thorax 51: 119-125, 1996.
231. SHAK, S. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. Chest 107, Suppl.: 65S-70S, 1995.
232. SHAPIRA, E., AND H. L. NADLER. Comparison of structural and functional properties of alpha 2-macroglobulin in controls and cystic fibrosis patients. Ann. NY Acad. Sci. 421: 352-359, 1983.
233. SHWACHMAN, H., AND I. ANTONOWICZ. Sweat test in cystic fibrosis. Ann. NY Acad. Sci. 93: 600, 1962.
234. SHWACHMAN, H., AND A. MAHMOODIAN. Pilocarpine iontophoresis sweat testing results of seven years experience. In: Modern Problems in Pediatrics, edited by E. Rossi and E. Stoll. Basel: Karger, 1967, p. 158-182.
235. SLEGERS, J. F. G. The mechanism of sweat secretion. Eur. J. Physiol. 279: 265-273, 1964.
236. SLEGERS, J. F. G. The Secretion and Reabsorption of Salt and Water in the Sweat Gland: a Comparative Study Between Normal Subjects and Patients Suffering From Fibrocystic Disease. Pflügers Arch. 290: 231-236, 1966.
237. SLEGERS, J. F. G. Patho-physiological studies of the sweat gland. Eur. J. Physiol. 290: 231-236, 1966.
238. SMITH, J. J., S. M. TRAVIS, E. P. GREENBERG, AND M. J. WELSH. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85: 229-236, 1996.
239. SPINO, M., R. P. CHAI, A. F. ISLES, J. W. BALFE, R. G. BROWN, AND J. J. THIESSEN. Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis. J. Pediatr. 107: 64-77, 1985.
240. SPOCK, A. Abnormal serum factor in patients with cystic fibrosis of the pancreas. Pediatr. Res. 1: 173-177, 1967.
241. STENVINKEL, P., L. HJELTE, G. ALVAN, A. HEDMAN, E. HULTMAN, AND B. STRANDVIK. Decreased renal clearance of sodium in cystic fibrosis. Acta Paediatr. Scand. 80: 1-13, 1991.
242. STEWART, B., J. ZABNER, A. P. SHUBER, M. J. WELSH, AND P. B. J. MCCRAY. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am. J. Respir. Crit. Care Med. 151: 899-903, 1995.
243. SUPER, M., AND D. J. VANSCHALKWYK. Heterozygote advantage in cystic fibrosis: mosquito tests. Clin. Genet. 16: 65-68, 1979.
244. SUTCLIFFE, C. H, P. P. STYLE, AND V. SCHWARZ. Biochemical studies of sweat secretion in cystic fibrosis. Proc. R. Soc. Med. 61: 297-300, 1968.
245. SWEENEY, E. A., AND J. H. SHAW. The effect of dietary pancreatic supplements on dental caries and on the composition of saliva in caries-susceptible rats. J. Dent. Res. 44: 973-976, 1964.
246. TABCHARANI, J. A., X. B. CHANG, J. R. RIORDAN, AND J. W. HANRAHAN. Phosphorylation-regulated Cl-channel in CHO cells stably expressing the cystic fibrosis gene. Nature 352: 628-631, 1991.
247. TAM, P. Y., AND P. VERDUGO. Control of mucus hydration as a Donnan equilibrium process. Nature 292: 340-342, 1981.
248. TANIZAH, Y., H. KITANI, M. OKAZAH, T. MIFUNE, F. MITSUNOBU, AND I. KIMURA. Mucus hypersecretion and eosinophils in bronchoalveolar lavage fluid in adult patients with bronchial asthma. J. Asthma 30: 257-262, 1993.
249. TAUSSIG, L. M., L. I. LANDAU, AND M. I. MARKS. Respiratory system. In: Cystic Fibrosis, edited by L. M. Taussig. New York: Thieme-Stratton, 1998, p. 85-174.
250. TAYLOR, C. J., P. S. BAXTER, J. HARDCASTLE, AND P. T. HARDCASTLE. Absence of secretory response in jejunal biopsy samples from children with cystic fibrosis. Lancet 2(8550): 107-108, 1987.
251. TAYLOR, C. J., P. S. BAXTER, J. HARDCASTLE, AND P. T. HARDCASTLE. Failure to induce secretion in jejunal biopsies from children with cystic fibrosis. Gut 29: 957-962, 1988.
252. TEUNE, T. M., A. J. TIMMERS-REKER, J. BOUQUET, J. BIJMAN, H. R. DE JONGE, AND M. SINAASAPPEL. In vivo measurement of chloride and water secretion in the jejunum of cystic fibrosis patients. Pediatr. Res. 40: 522-527, 1996.
253. THOMAIDIS, T. S., AND J. B. AREY. The intestinal lesions in cystic fibrosis of the pancreas. J. Pediatr. 63: 444-453, 1963.
254. TRAVIS, S. M., M. R. CARSON, D. R. RIES, AND M. J. WELSH. Interaction of nucleotides with membrane-associated cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 268: 15336-15339, 1993.
255. TSUI, L.-C., M. BUCHWALD, D. BARKER, J. C. BRAMAN, R. KNOWLTON, J. W. SCHUMM, H. EIBERG, J. MOHR, D. KENNEDY, AND N. PLAVSIC. Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science 230: 1054-1057, 1985.
256. TUMMLER, B., E. SEGER, AND J. R. RIORDAN. Systematic study of the hydrolysis of 4-methylumbelliferylguanidinobenzoate in plasma from patients with cystic fibrosis and controls. Clin. Chim. Acta 125: 219-232, 1982.
257. VAWTER, G. F., AND H. SHWACHMAN. Cystic fibrosis in adults: an autopsy study. Pathol. Ann. 14: 357-382, 1979.
258. VAYSSE, N., J. LAVAL. M. DUFFAUT, AND A. RIBET. Effect of secretin and graded doses of CCK-PZ on pancreatic secretion in man. Am. J. Dig. Dis. 19: 887-894, 1974.
259. WALSH-PLATT, M., G. J. RAO, AND H. L. NADLER. Protease deficiency in plasma of patients with cystic fibrosis. Reduced reaction of 4-methylumbelliferylguanidinobenzoate with plasma of patients with cystic fibrosis. Enzyme 24: 224-229, 1979.
260. - channels. Proc. Natl. Acad. Sci. USA 88: 5277-5281, 1991.
261. WEISMANN, U. N., T. F. BOAT, AND P. A. DI SANT'AGNESE. Flowrates and electrolytes in minor-salivary-gland saliva in normal subjects and patients with cystic fibrosis. Lancet 2(7776): 510-512, 1972.
262. WELSH, M. J. An apical-membrane chloride channel in human tracheal epithelium. Science-232: 1648-1650, 1986.
263. WELSH, M. J., M. LI, J. D. MCCANN, J. P. CLANCY, AND M. P. ANDERSON. Phosphorylation-dependent regulation of apical membrane chloride channels in normal and cystic fibrosis airway epithelium. Ann. NY Arad. Sci. 574: 44-51, 1989.
264. WELSH, M. J., AND B. W. RAMSEY. Research on cystic fibrosis: a journey from the Heart House. Am. J. Respir. Crit. Care Med. 157, Suppl.: S148-S154, 1998.
265. WIDDICOMBE, J. H., AND R. A. BARTHELSON. Electrical properties of cultured reabsorptive sweat duct cells from normal and cystic fibrosis subjects: intracellular microelectrode analysis. In: Cellular and Molecular Basis of Cystic Fibrosis, edited by G. Mastella and P. M. Quinton. San Francisco, CA: San Francisco Press, 1988, p. 377-382.
266. WIJCIK, L., M. BUCHWALD, AND J. R. RIORDAN. Induction of alkaline phosphatase in cultured human fibroblasts. Comparison of normal cells and those from patients with cystic fibrosis. Biochim. Biophys. Acta 585: 374-382, 1979.
267. WILL, P. C., A. TAYLOR, J. L. LEBOWITZ, D. G. DEARBORN, AND U. HOPFER. Saliva from patients with cystic fibrosis inhibits amiloride-sensitive sodium transport. Pediatr. Res. 14: 1245-1249, 1980.
268. WILSON, G. B., P. ARNAUD, M. T. MONSHER, AND H. H. FUDENBERG. Detection of cystic fibrosis protein by electrofocusing. Pediatr. Res. 10: 1001-1002, 1976.
269. WILSON, G. B., H. H. FUDENBERG, M. T. PARISE, AND E. FLOYD. Cystic fibrosis ciliary dyskinesia substances and pulmonary disease. J. Clin. Invest. 68: 171-183, 1981.
270. WILSON, J. R., AND R. O. DUBOIS. Report of a fatal case of keratomalacia in an infant, with postmortem examination. Am. J. Dis. Child. 26: 431-446, 1923.
271. - channels. FASEB J. 15: 1-15, 1990.
272. YAFFE, S. J., L. M. GERBRACHT, L. L. MOSOVICH, M. E. MATTAR, M. DANISH, AND W. J. JUSKO. Pharmacokinetics of methicillin in patients with cystic fibrosis. J. Infect. Dis. 135: 828-831, 1977.
273. YOUNGBERG, C. A., R. R. BERARDI, W. F. HOWATT, M. L. HYNECK, G. L. AMIDON, J. H. MEYER, AND J. B. DRESSMAN. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Dig. Dis. Sci. 32: 472-480, 1987.
274. ZABNER, J., J. J. SMITH, P. H. KARP, J. H. WIDDICOMBE, AND M. J. WELSH. Loss of CFTR chloride channels alters salt absorption by cystic fibroisis airway epithelia in vitro. Mol. Cell. Biol. In press.
275. ZEULER, W. W., AND W. A. NEWTON. The pathogenisis of fibrocystic disease of the pancreas. A study of 36 cases with special reference to the pulmonary lesions. Pediatrics 4: 53-69, 1949.